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Background The ACCESS Programme aims at understanding and improving
access to prompt and effective malaria treatment in rural
Tanzania with a set of integrated interventions targeting both
users and providers. The aim of this article is to evaluate the pro-
gramme’s impact on the community and health facility burden of
malaria and to investigate the value of community-based reporting
for routine malaria control programme monitoring.
Methods This work was implemented within the Ifakara Demographic
Surveillance System (DSS) between 2004 and 2008. At community
level the DSS staff routinely collected data on reported history of
fever and severe malaria (convulsions) based on a 2-week recall. In
parallel, we collected in-patient and out-patient fever and malaria
diagnoses data from the 15 health facilities in the area. Treatment-
seeking surveys conducted in the study area and nationally repre-
sentative data were used to validate our measure of community
fever.
Results Between 2005 and 2008, community-reported fever incidence rates
in children under the age of 5 years declined by 34%, from 4.9 to
3.2 average cases per child per year, whereas convulsions, a marker
of severe malaria morbidity in children, decreased by 46%, from
4263 to 2320 cases for every 100 000 children per year. The decrease
in the community rates was paralleled by a decrease in the health
facility fever rates, although the number of fever cases seen in
health facilities did not change because of population growth. Our
data showed very good internal and external consistency with in-
dependent local and national surveys.
Conclusions There is an evidence of a substantial decline in the community
burden of malaria morbidity between 2005 and 2008 in the
Kilombero and Ulanga DSS areas in Tanzania, most likely as a
result of malaria control efforts. The good internal and external
consistency of the data shows that history of fever in the previous
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2 weeks in children under the age of 5 years can be used as a
morbidity monitoring tool.
Keywords Malaria, morbidity, fever, seizures, programme evaluation
‘Without high quality surveillance, the billion
dollar malaria effort is flying blind’.1
Background
The massive increase in resources mobilized for mal-
aria control calls for careful monitoring to ensure that
money is spent effectively. Surveillance data are cru-
cial at country level to know when targets are met
and even more importantly to initiate mid-course cor-
rections if progress is inadequate. Reliable evaluation
data are also important as an evidence base to
up-scale effective new interventions. The need for a
comprehensive monitoring and evaluation plan has
been recognized by donors and international technical
agencies. This has led to the development of a com-
prehensive Monitoring and Evaluation (M&E) toolkit
by the Global Fund to fight AIDS, TB and Malaria
(GFATM) to assist countries in developing robust
M&E systems.2
The GFATM’s M&E toolkit is based on the widely
applied input–output–outcome-impact framework and
includes mortality and morbidity impact indicators.
Mortality indicators are based on robust and validated
methodologies.3,4 They are widely used for the evalu-
ation of malaria control efforts since the data can be
obtained from nationally representative, cross-
sectional retrospective surveys such as the
Demographic Health Surveys (DHS)5 and the
Multiple Indicator Cluster Surveys (MICS).6
However, mortality is multi-factorial and it is always
difficult to tease apart the effect of malaria control
from secular trends. The recommended morbidity in-
dicators are parasite prevalence and anaemia preva-
lence. The Malaria Indicator Survey (MIS)7 was
especially designed to capture these two measures.
Although the DHS, MICS and MIS also collect history
of fever during the past 2 weeks, this measure is not
widely used as a morbidity indicator and is not rec-
ommended in the M&E toolkit. Instead, it is used as a
basis for operational indicators such as ‘the percent-
age of children with fever in the previous 2 weeks
who were treated with an antimalarial drug’.
However, although parasite prevalence gives import-
ant information regarding the impact of control ef-
forts on malaria transmission,8 it is not directly a
morbidity indicator. In high-endemicity areas, control
efforts may first have an impact on fever and then
only later on prevalence due to the reduction of multi-
plicity of infections that reduces clinical episodes.9
Anaemia prevalence has been shown to be a reliable
indicator of malaria morbidity but is also an indirect
measure with multi-factorial causality.10
The ACCESS Programme was implemented in two
Tanzanian districts with the aim of improving access
to malaria treatment. The programme’s interventions
are based on an integrated approach, which targets
both users and providers, and were accompanied by
M&E activities.11 Between 2004 and 2008, the
ACCESS Programme’s main intervention at user
level was the implementation of social marketing
campaigns for improved care seeking. At provider
level, key activities in health facilities included
strengthening routine supportive supervision and the
implementation of a quality management scheme. In
parallel, the Accredited Drug Dispensing Outlets
(ADDO) programme was piloted in the study area
from 2006 onwards to improve the availability of
drugs and quality of care people obtain from the
private retail sector.12
The ACCESS M&E plan included the measurement
of output, outcome and impact indicators. Provider
and user surveys conducted within the frame of the
programme showed an improvement in access out-
puts and treatment outcomes,13,14 although treatment
with anti-malarials was already very high at base-
line.15 The proportion of recent fever cases treated
with an anti-malarial increased from 86% to 96% be-
tween 2004 and 2008. This article is concerned with
the programme’s impact on morbidity and aims at
assessing changes in the community and health facil-
ity burden of malaria between 2004 and 2008.16 In
this frame, we investigated the value of collecting his-
tory of fever in the previous 2 weeks at community
level as a morbidity monitoring tool.
Methods
Study setting
The ACCESS Programme’s monitoring and evaluation
activities were embedded within the Kilombero and
Ulanga DSS (Figure 1). It was established in 1996
and covers 25 villages (13 in Kilombero District and
12 in Ulanga District). The population in 2004 was
almost 74 000 and it increased to just over 92 000 in
2008. There are six health facilities (one health centre
and five dispensaries) in the Kilombero area and eight
health facilities (one health centre and seven dispen-
saries) in Ulanga. Malaria transmission was intense
and perennial with an entomological inoculation rate
(EIR) of 350,17 but has been declining over the past
10 years.18 The area is characterized by a rainy season
406 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
from November to May, with rain levels consistently
increasing month by month until April.19 More details
on the study area can be found elsewhere.11,20
Data collection and processing
We collected data at community and health facility
level between 2004 and 2008 with three independent
instruments. The community-based data included: (i)
the collection of history of fever and convulsions in
the previous 2 weeks with DSS-based surveys and;
(ii) three cross-sectional treatment-seeking surveys
in 2004, 2006 and 2008 to elicit information about
people’s actions in the event of fever. At health facil-
ity level, we collected Health Management and
Information Systems (HMIS) data from all the dis-
pensaries and health centres in the area.
History of fever and convulsions
We integrated the collection of community reported
fever and convulsions cases within the routine DSS
data collection activities between May 2004 and
December 2008. Whereas fever (locally termed
homa) is a proxy indicator for uncomplicated malaria,
convulsions (degedege) are a sign of severe febrile ill-
ness, which includes cerebral malaria in children.21,22
Both signs are not highly specific for malaria, but
under the assumption that other causes remain
stable, they provide useful markers of malaria mor-
bidity. This is a reasonable assumption in our study
areas, since there was no major intervention or event
over the study period that could have led to the pre-
vention of new fever cases. DSS field workers visited
every household in the area at 4-month intervals
(three rounds per year) to collect data on birth,
death, in-migration and out-migration. Field workers
collected information at village level by following a
fixed schedule of household visits. Therefore, al-
though each household was visited only every 4
months, data were effectively collected on a daily
basis in each village. Given that each recorded case
refers to fever in the past 2 weeks, each interviewed
individual contributes 2 person-weeks of observation.
We, therefore, constructed the following
approximated monthly fever and convulsions inci-
dence rates for each of the 25 DSS villages, expressed
in cases per 1000 person-weeks (c/1000 pw):
community fever rate
¼ number of community reported fever cases per month
total number of people interviewed per month  2
community convulsions rate
¼number of community reported fever convulsions per month
total number of people interviewed per month  2
Unfortunately, due to logistical constraints, the data
could only be collected on two-thirds of the DSS
population. However, there was no indication that
certain villages were consistently less visited than
others and the distribution across ages was similar
in every round and reflective of the DSS age distribu-
tion. It is, therefore, unlikely that the incomplete
coverage is biasing our estimates.
Treatment-seeking surveys
In 2004, 2006 and 2008, a village stratified random
sample of approximately 100 community-reported
fever cases were followed up with treatment-seeking
surveys. These surveys were conducted by the DSS
field workers between May and August each year
(second round of data collection). Patients who had
not recovered were not interviewed and they were
instead advised to seek care from a health facility.
For the purpose of this analysis, we only analysed
the data providing information on the proportion
of fever cases brought to a health facility at some
point during the illness. A detailed analysis of the
treatment-seeking surveys is presented elsewhere.14
HMIS data from dispensaries and health centres
Health facility data were collected by specifically
trained field workers who visited all the 14 facilities
in the area (2 health centres and 12 dispensaries) on
a 2-monthly basis between January 2004 and
December 2008. The data collected included all
in-patient and out-patient diagnoses disaggregated
Figure 1 Location of the Ifakara DSS site [source: INDEPTH Monograph (20)]
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by age group (children under the age of 5 years and all
other patients) on a monthly basis. We created health
facility catchment areas based on the villages in which
facilities are located. Some catchment areas included
more than one health facility or more than one village
because: (i) some villages do not have a health facility
but are located close to a village which does; and (ii)
some villages have more than one health facility. By
combining the data from the health facilities with the
person time exposure data from the DSS database, we
calculated the following monthly health facility fever
and malaria incidence rates (c/1000pw) for each
health facility catchment area:
Health facility fever rate
¼
ðmalaria þ pneumonia þ respiratory infections þ measlesþ
typhoid þ urinary tract infectionsÞ diagnoses per month
person-weeks exposed per month ðDSSÞ
Health facility malaria rate
¼ malaria diagnoses per month
person-weeks exposed per month ðDSSÞ
Mean imputation was carried out for the months
where the data could not be obtained from health
facilities: missing entries for a given month in a
given health facility were replaced by the mean
number of patients seen in the health facility in the
year of observation. This method was considered ap-
propriate since only 7.7% (153/1984) records were
missing and data were seldom missing for more
than one facility in the same month. This approach,
therefore, did not have an effect on the seasonality of
the rates.
Statistical analysis
We first estimated trends over time of the community
fever and convulsions as well as the health facility
fever and malaria rates. We then explored the validity
of monitoring history of fever at community level by
assessing the internal and external consistency of our
data with surveys conducted in the study area and
nationally representative surveys.
Trends over time
Random effects Poisson regression models were fitted
to estimate changes in the community and health
facility burden of malaria. The fever, convulsions
and malaria cases N in village or catchment area
i were assumed to have arisen from a Poisson distri-
bution, as is most appropriate for count data. We thus
assumed that the rate of incidence is constant for
every individual and that the variance is equal to
the mean. Hence, the following model was fitted:
logi ¼logðYiÞ þ þ 1yeari þ 2month 2iþ
   þ 12 month 12i þ ui
(Model 1)
where i is the expected value of the rate Ni/Yi in
village or catchment area i, Yi are the person-weeks
exposed per month and logðYiÞ is an offset term that
ensures that the rate is being modelled on the log
scale. The coefficient a is the intercept term. Year is
a continuous variable (from 2004 to 2008) and the
exp(1) is the estimated incidence rate ratio (IRR)
of changes over the years and months. Month is a
categorical variable denoting month of the year
(from 1 to 12), which ensures that the estimate of
exp(1) is not confounded by monthly variations
(seasonality). The random effect ui explicitly
allows for the clustering of rates in villages or catch-
ment areas i and is assumed to follow a g distribu-
tion ui   1= , ð Þ which implies a mean 1 and
variance a.
Internal consistency
To address the internal consistency of our data, we
first correlated the health facility fever and commu-
nity fever monthly rates to assess the temporal correl-
ation between the two sources of data. We then fitted
a Poisson regression to estimate the proportion of
fever cases in the community that are brought to a
health facility as well as changes in this proportion
over time. These estimates were compared with
independent information from the treatment-seeking
surveys. For this purpose, cases and exposures were
aggregated over villages and health facilities and the
following models were fitted:
log ¼logðYÞ þ þ 1yearþ2month 2 þ   
þ12 month 12 þ 1 HF
(Model 2)
log ¼logðYÞ þ þ 1year þ 2month 2 þ   
þ12month 12 þ 1HF þ 2HFyear
(Model 3)
where HF indicates the type of case that is being
modelled and takes the value of 1 if the cases are
health facility-recorded cases and 0 if the cases are
community reported. The coefficient exp(1) in
Model 2 is an estimate of the ratio of health facility
rates to community rates and therefore provides an
estimate of the proportion of fever cases in the
community that are brought to a health facility. The
coefficient exp(2) of the interaction between type of
case and year in Model 3 estimates the change over
time of the proportion of fever cases brought to a
health facility.
External consistency
To assess the external consistency of our data, we
compared our estimates with data from the 2004/05
DHS23 and 2007/08 MIS.24 Both surveys were carried
out on a nationally representative sample of the popu-
lation between October and January. First, we com-
pared the decrease in community fever from our
surveys between 2004 and 2007 with the decrease in
fever reported in the DHS and MIS. We then com-
pared the decreases in fever rates with decreases in
under-5 mortality in both settings. Under-5 mortality
rates for our study area were obtained from the DSS
for 2004 and 2007 and were expressed as the number
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of cases per 1000 person-years (c/1000 py). Nation-
wide estimates of under-5 mortality for 2004 and
2007 were derived by disaggregating the 2007/08
MIS estimate using the methodology described by
Masanja et al.25 and are expressed as a probability
of dying between birth and the fifth birthday for
every 1000 live births (5q0).
All data were double entered using Microsoft FoxPro
and Microsoft Access (Microsoft Corp., Seattle, USA)
and checked for coding errors and consistency.
Intercooled Stata 10 (Stata Corp., College Station,
TX, USA) was used for data management and
analysis.
Ethics
The National Institute for Medical Research of the
United Republic of Tanzania (NIMR/HQ/R.8a/Vol.IX/
236, 16 September 2003) granted ethical clearance
for the study.
Results
The number of fever cases reported in 2004 appeared
to be unrealistically high at community level and un-
realistically low at health facility level (Table 1 and
Figure 2) compared with the values in subsequent
years. A visual inspection of the rates suggests that
more accurate reporting was achieved both at com-
munity level (Figure 2a and b) and in health facilities
(Figure 2c and d) after a year of data collection. Fever
rates at community level were much higher in the
first year of data collection compared with subsequent
years, suggesting over-reporting of cases when the
questions on incidence of fever were asked for the
first time. Conversely, fever rates at health facility
level were much lower and less seasonally variable
in the first year of data collection suggesting that
many cases were not recorded. All the 2004 data
were, therefore, excluded from any analysis.
The community fever and convulsions rates follow a
clear seasonal pattern and have been decreasing over
time. Seasonal peaks correspond with the middle of
the rainy season (January–March) (Figure 2a and b).
The rates averaged over the year show a constant de-
crease in community fever rates between 2005 and
2008 from 47.2 c/1000pw (16 350/34 6311) to 34.4
c/1000pw (11 567/33 6475) in all ages. This corres-
ponds to a decrease from 2.5 to 1.8 average cases
per person per year, i.e. an overall reduction of 28%.
In children under the age of 5 fever rates decreased by
34% from 93.9 c/1000pw (5298/56403) to 61.6
c/1000pw (3419/55 490), which means a decrease
from 4.9 cases to 3.2 cases per child per year.
Convulsions are a much rarer event than fever and
also decreased. Convulsion rates were 0.82 c/1000pw
(284/346 427) in 2005 (4263 cases for every 100 000
children per year) and 0.45 c/1000pw (152/340.667) in
2008 (2320 cases for every 100 000 children per year)
which is equivalent to an overall reduction of 46%
(Table 1).
The health facility rates exhibited much less season-
al variation and there was a less discernable pattern
of change over time (Figure 2c and d). Between 2005
and 2007, there appeared to be a trend of increasing
rates but this was followed by a low value in 2008
driven by a particularly low attendance in one of the
health centres. In 2005, the median number of pa-
tients recorded per month was 523 (IQR¼ 339–658)
in dispensaries and 856 (IQR¼ 693–1079) in health
centres. These figures hardly changed in 2008 when
the median number of patients recorded per month
was still 523 (IQR¼ 347–410) in dispensaries and 840
(IQR¼ 745–1220) in health centres. Between 2005
and 2008, malaria diagnoses consistently accounted
for 67.4% of all fever cases in all the months of
data collection (Table 1, Figure 2c and d).
Trends over time
Fitting Model 1 on the community-reported rates
shows a decrease in the incidence of both fever and
convulsions. Overall community fever decreased by
10% per year [IRR¼ 0.90, 95% confidence interval
(95% CI)¼ 0.87–0.89] between 2005 and 2008. Rates
decreased more steeply in children under the age of
Table 1 Community and health facility cases between 2004
and 2008
Level
Type of
cases Year Cases
Person-weeks
of observation
Community Fever 2004 18 844 289 764
2005 16 350 346 311
2006 14 032 329 306
2007 18 691 451 228
2008 11 567 336 474
Convulsions 2004 590 291 321
2005 284 346 427
2006 213 330 576
2007 292 451 292
2008 152 340 666
Health facility Fever 2004 52 875 3 579 456
2005 67 335 3 573 468
2006 65 342 3 729 097
2007 77 398 3 818 092
2008 65 223 4 008 284
Malaria 2004 35 011 3 579 456
2005 45 931 3 573 468
2006 44 562 3 729 097
2007 55 788 3 818 092
2008 42 358 4 008 284
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5 at a rate of 13% per year (IRR¼ 0.87, 95% CI¼ 0.85–
0.87) (Table 1 and Figure 2). The incidence of con-
vulsions in children also decreased considerably over
the study period at an estimated rate of 21% per year
(IRR¼ 0.79, 95% CI¼ 0.74–0.92).
Model 1 was also used to estimate the extent to
which the community fever cases were over reported
in the first year of data collection (first round
January–April 2004 but data were only collected
from March onwards, second round May–August
2004 and third round September to December 2004).
The extrapolation suggests an overall overestimation
of 79.6% in the first round of collection (actual
number of cases reported 9456 vs estimated 5265
for 83 434 person-weeks of observation); 43.7% in
the second round of data collection (6432 vs 4469
cases for 95 718 person-weeks) and 39.7% in the
third round (6048 vs 4329 cases for 99 087 person-
weeks).
Health facility rates were also estimated to have
decreased over the study period, but to a much
lesser extent. The IRR of fever and malaria rates in
adults over time were estimated at values very close
to one (fever: IRR¼ 0.98, 95% CI¼ 0.98–0.98; malaria:
IRR¼ 0.97, 95% CI¼ 0.97–0.98) suggesting an only
very slight decrease over time. A more appreciable
decrease was estimated for rates in children; health
facility fever rates were estimated to have decreased
by 6% per year (IRR¼ 0.94, 95% CI¼ 0.94–0.95) and
malaria rates by 7% per year (IRR¼ 0.93, 95%
CI¼ 0.92–0.93) (Table 3).
Accounting for the seasonality of the data by includ-
ing a categorical factor for the month of the year did
not affect the estimated change over time. The
log-likelihood ratio test for the inclusion of months
of the year was highly significant in all the models
estimating trends over time (Tables 2 and 3).
However, the inclusion of this variable only affected
slightly the size of the IRR estimating the changes
over the years in the community rates. More specific-
ally, the models fitted excluding months of the year
overestimated the decrease over time, but only by 1%
point (fever all ages: IRR¼ 0.90, 95% CI¼ 0.89–0.91;
fever children < 5 years: IRR¼ 0.86, 95% CI¼ 0.85–
0.88; convulsions: IRR¼ 0.78, 95% CI¼ 0.74–0.84).
The exclusion of the variable did not affect the size
of the IRRs for the health facility rates at all.
The inclusion of a random effect to account for the
fact that different villages or catchment areas might
have different rates did not affect the estimated
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Figure 2 Community and health facility rates (note: y-axes differ across graphs)
410 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
change over the years either. However, the variance a
of the random effects was significantly different from
zero in all the models fitted (Tables 2 and 3), suggest-
ing that there is clustering between villages or catch-
ment areas and that random effects should be
included in the models to account for this.
Internal and external consistency of the data
The community fever rates correlate very well with
fever rates from health facilities in children under
the age of 5 years (r¼ 0.81, P< 0.001) but less so in
all patients (r¼ 0.67, P< 0.001) (Figure 3).
Combining the fever rates at health facility and
community level and comparing the results with the
treatment seeking surveys shows reasonable but not
all round internal consistency. According to the inde-
pendent cross-sectional treatment seeking surveys,
the proportion of fever cases brought to a health fa-
cility did not change significantly between 2006 and
2008 and was estimated 68% in children and 65% in
all ages [children from 67.3% (37/55) in 2006 to
69.2% (27/39) in 2008 OR¼ 1.05 95% CI¼ 0.67–1.63,
all patients 61.2% (63/103) in 2006 to 69.7% (60/86)
in 2008 OR¼ 1.21 95% CI¼ 0.89–1.64]. Model 2 esti-
mated the proportion of fever cases brought to a
health facility to be 72% (IRR¼ 0.72, 95% CI¼ 0.70–
0.73) in children under the age of 5 years and 45%
(IRR¼ 0.45, 95% CI¼ 0.45–0.46) in all patients be-
tween 2006 and 2008. According to Model 3, the
proportion of fever cases brought to a health facility
increased by 8% per year (IRR¼ 1.08, 95% CI¼ 1.07–
1.10) in children and by 9% per year in all patients
(IRR¼ 1.09, 95% CI¼ 1.08–1.10) between 2006 and
2008. Hence, the estimated proportion of fever cases
brought to a health facility was the same according to
the treatment-seeking surveys and Model 2 in chil-
dren (but not in adults); and Model 3 suggests a
higher increase over time in proportion of fever
cases brought to a health facility compared with the
treatment seeking surveys.
There is very good external consistency between our
data and data from the national DHS and MIS. These
surveys report a decrease in the percentage of fever in
the past 2 weeks from 25% for the period October
2004 to January 2005 to 18% for the period October
2007 to January 2008. This is equivalent to a 26%
decrease in fever prevalence over the 3 years of obser-
vation. This was associated with an 8% decrease in
mortality from 97.2 5q0 in 2004 to 89.5 5q0 in 2007
(ratio of fever to mortality decrease¼ 3.3). An ex-
trapolation of our fever data (Model 1) estimated a
fever incidence of 107.3 c/1000pw for the period
October 2004 to January 2005 and 73.2 c/1000pw
for the period October 2007 to January 2008. This is
equivalent to a 32% decrease in fever, very close to the
26% decrease at national level. In the Kilombero and
Ulanga DSS, this was associated with a 12% decrease
in mortality from 25.3 c/1000py to 22.2 c/1000py
(ratio of fever to mortality decrease¼ 2.6).
Table 2 IRRs (95% CI) from random effects Poisson regressions fitted on monthly community fever and convulsion rates
(2005–08)
Fever
Convulsions
All ages (n¼ 1064) <5 years (n¼ 1047) <5 years (n¼ 1046)
Year 0.90 (0.87–0.89) 0.87 (0.85–0.87) 0.79 (0.74–0.92)
Montha
January 1 1 1
February 1.01 (0.97–1.05) 0.99 (0.91–1.07) 1.32 (0.90–1.94)
March 0.91 (0.88–0.95) 0.89 (0.82–0.97) 1.02 (0.70–1.50)
April 0.86 (0.82–0.90) 0.83 (0.75–0.91) 1.03 (0.66–1.61)
May 0.74 (0.70–0.78) 0.70 (0.63–0.77) 0.83 (0.52–1.34)
June 0.70 (0.66–0.72) 0.66 (0.61–0.72) 0.65 (0.43–0.97)
July 0.62 (0.59–0.65) 0.61 (0.58–0.68) 0.62 (0.41–0.94)
August 0.61 (0.57–0.65) 0.60 (0.54–0.68) 0.68 (0.39–1.20)
September 0.71 (0.67–0.74) 0.79 (0.72–0.87) 1.04 (0.67–1.62)
October 0.63 (0.60–0.65) 0.71 (0.66–0.77) 0.74 (0.49–1.11)
November 0.57 (0.54–0.60) 0.66 (0.61–0.72) 0.63 (0.41–0.97)
December 0.54 (0.50–0.57) 0.60 (0.53–0.68) 0.47 (0.24–0.89)
ab 0.07 (0.04–0.12) 0.04 (0.02–0.08) 0.20 (0.11–0.38)
aLLR test of inclusion—fever all ages: 2¼ 2514.23, P< 0.001; <5 years: 2¼ 562.93, P< 0.001; convulsions: 2¼ 63.27 P< 0.001.
bg-Distributed random effects (95% CI) to account for between-village variance.
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Figure 3 Community fever rates and health facility fever rates by age group between 2005 and 2008
Table 3 IRRs (95% CI) from random effects Poisson regressions fitted on monthly health facility fever and malaria rates
(2005–08, n¼ 432)
Fever cases Malaria diagnoses
All ages <5 years All ages <5 years
Year 0.98 (0.98–0.98) 0.94 (0.94–0.95) 0.97 (0.97–0.98) 0.93 (0.92–0.93)
Montha
January 1 1 1 1
February 1.00 (0.98–1.02) 0.99 (0.97–1.01) 0.99 (0.97–1.01) 0.97 (0.95–1.00)
March 0.91 (0.89–0.92) 0.92 (0.89–0.93) 0.86 (0.85–0.88) 0.87 (0.84–0.89)
April 0.86 (0.84–0.87) 0.94 (0.92–0.96) 0.77 (0.76–0.79) 0.85 (0.83–0.87)
May 0.89 (0.87–0.91) 0.87 (0.85–0.89) 0.81 (0.79–0.83) 0.79 (0.76–0.81)
June 0.87 (0.85–0.88) 0.85 (0.83–0.87) 0.79 (0.77–0.81) 0.78 (0.75–0.80)
July 0.80 (0.78–0.81) 0.77 (0.76–0.79) 0.74 (0.72–0.75) 0.72 (0.70–0.74)
August 0.84 (0.82–0.85) 0.81 (0.79–0.83) 0.78 (0.76–0.79) 0.76 (0.74–0.79)
September 0.90 (0.88–0.91) 0.89 (0.87–0.92) 0.83 (0.81–0.85) 0.84 (0.82–0.86)
October 0.87 (0.85–0.88) 0.90 (0.88–0.92) 0.82 (0.80–0.83) 0.85 (0.83–0.86)
November 0.90 (0.88–0.91) 0.88 (0.86–0.91) 0.83 (0.81–0.84) 0.83 (0.81–0.86)
December 0.78 (0.77–0.79) 0.76 (0.74–0.77) 0.74 (0.72–0.75) 0.73 (0.71–0.76)
ab 0.30 (0.12–0.72) 0.36 (0.15–0.86) 0.23 (0.10–0.57) 0.27 (0.11–0.65)
aLLR test of inclusion—fever all ages: 2¼ 1440.82, P< 0.001; <5 years: 2¼ 1063.87, P< 0.001; malaria diagnoses for all ages:
2¼ 1730, P< 0.001; <5 years: 2¼ 1005.58, P< 0.001.
bg-Distributed random effects (95% CI) to account for between catchment area variance.
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Discussion
The data presented here document a decline in mal-
aria morbidity between 2005 and 2008 in the highly
malaria-endemic Kilombero and Ulanga DSS areas.
Community-reported fever incidence rates declined
by 10% per year in the overall population and by
13% per year in children under the age of 5 years.
There is also an indication of a decrease in severe
malaria morbidity as indicated by a 21% decrease in
the incidence of reported convulsions in children. The
decrease in the community burden of malaria in chil-
dren is accompanied by decrease in the health facility
fever and malaria rates in children (6 and 7% per
year, respectively) but not as much in the overall
population (2 and 3% per year). However, due to
population growth, the average number of cases per
month in health facilities remained constant, imply-
ing that there was no change in the health facility
burden of fever and malaria.
Data from separate studies conducted in the study
area provide evidence that the declines in community
fever and convulsion rates are paralleled by a decline
in malaria transmission. Data from two other projects
documented a decrease in parasitaemia in children
under the age of 5 years from 25% in 2004 to 10%
in 2008.26,27 Similarly, an older study reported an EIR
of 349 infective bites per person per year (ib/p/y) be-
tween 2001 and 2003,17 whereas by 2008 the EIR had
declined to 81 ib/p/y.18 In parallel, under-five mortal-
ity decreased from 24.5 c/1000py to 18.9 c/1000py
between 2004 and 2008.28 These data give us
confidence that the decrease we observed in fever
rates is to a large extent malaria related, although
we could not assess independently the proportion of
true malaria cases among all the fever episodes.
The increased treatment coverage is very likely to
have contributed to the decrease in morbidity. The
first line treatment for malaria in Tanzania was sul-
phadoxine pyrimethamine (SP) until 2006 when it
was replaced by the artemisinin combination therapy
(ACT) artemether–lumefantrine (ALu). The long half-
life of SP29 and its prophylactic effect have been clear-
ly documented.30 The treatment of any potential
malaria case with SP not only clears parasites in
true cases of malaria but also provides chemoprophy-
laxis for up to 4 weeks in those who were and those
who were not infected, which in turn reduces the
parasite burden in individuals and the infectious res-
ervoir in the community. This has led to the hypoth-
esis that widespread presumptive treatment with the
drug contributes to a decrease in transmission, based
on the observation that malaria started decreasing in
Kenya before the widespread use of insecticide-
treated nets (ITNs).31 ACTs do not have a prophylactic
effect, but do have gametocidal properties32–34 and
hence it has been suggested that ACTs can have an
impact on transmission.35 In our study area, malaria
treatment has reached very high levels with an in-
crease in the proportion of fever cases treated with
an anti-malarial from 86% in 2004 to 96% in 2008.
SP was used to treat 30–40% of all identified cases
between 2004 and 2008, whereas ALu was used in a
40% of cases in 2008. Hence, it is reasonable to
ascribe part of the observed decrease in
malaria-related fevers to improved treatment.
The increased vector control in the area over the
same period also explains in part the decrease in mal-
aria transmission and morbidity rates. A very high
mosquito ITN coverage has been achieved in the
study area following the nation-wide up-scaling17,36
of the KINET scheme for the promotion and subsid-
isation of nets.37 However, much of the increase in
ITN coverage happened before our assessment and
ITN coverage remained largely unchanged between
2005 and 2008, with over 90% of household owner-
ship. This does not rule out continued effect over time
since recent modelling work suggests that sustaining
coverage with ITN at such levels may lead to constant
decreases in transmission, even if coverage does not
increase (Prof. T. Smith, personal communication,
Swiss Tropical and Public Health Institute, Basel).
Furthermore, most nets were untreated in 200517
whereas by 2008 nearly half of the nets were trea-
ted.18 A recent study concluded that the addition of
long-lasting insecticide treatment of bednets in the
area was able to reduce the intensity of malaria trans-
mission 4.6-fold.18 Increased IPTp may also have
played a role in decreasing morbidity, especially in
children.38 According to regional data the proportion
of women who received two doses of SP during their
pregnancy increased from 23% in 2004 to 44% in
2007.23,24
The good internal and external consistency of our
data shows that reported history of fever in the pre-
vious 2 weeks can be used to monitor the community
burden of malaria in children under the age of 5 years
reliably in highly malaria endemic areas. Our data are
internally consistent since, we were able to show that:
(i) community fever rates were very highly correlated
health facility fever rates in children under the age of
5 years; and (ii) estimates of health facility attend-
ance for fever (i.e. the proportion of fever cases in the
community brought to a health facility) resulting
from the ratio of health facility to community rates
are similar to those obtained from an independent
treatment-seeking survey. In addition, our data
showed good external consistency with national sur-
veys. Although a slightly lower decrease in incidence
of fever was observed at national level compared to
our study site between 2004 and 2007 (25% vs 32%),
the ratio of fever incidence decrease to under-five
mortality decrease was comparable in both settings
(3.3 vs 2.5). This finding is of high interest to malaria
control programmes because it offers for the first time
a validated community-based measure of malaria
morbidity that can be used for monitoring. It follows
that fever recall data collected by representative
household surveys such as the DHS, MICS and MIS
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can be analysed to monitor morbidity trends and
impact.
However, there is an important caveat associated
with the use of fever recall as a morbidity monitoring
tool. Our experience shows that cases are substantial-
ly over-reported when the question: ‘Have you had
fever in the past 2 weeks?’ is asked for the first
time, and this is consistent with findings from other
studies.39,40 A possible explanation is that respond-
ents do not only report episodes which occurred in
the past 2 weeks but also previous ones. According
to our data, respondents are better able to limit re-
porting to episodes that occurred strictly within the
requested time interval after three rounds. Therefore,
fever rates based on a 2-week recall in cross-sectional
household surveys such as the DHS, MICS and MIS
are likely to be over-estimated. Fortunately, consist-
ency checks between our data and the 2007/08
Tanzania MIS and the 2004/05 DHS suggested that
over-reporting is consistent between surveys and
therefore does not jeopardise the comparability of
data collected in the frame of different surveys and
these estimates can still be used to assess changes
over time. However, it implies that such data should
not be used, for example, to derive the number of
fever-related commodities required in a given popula-
tion (typically anti-malarial drugs and diagnostic
tests) as estimates are likely to be too high.
Unfortunately, we were not able to validate the use
of history of convulsions in the past 2 weeks in the
frame of this study. It can be argued that the inci-
dence of convulsions is the only marker of severe mal-
arial disease that can be monitored at community
level. There is evidence from a hospital study con-
ducted in the Kilifi District Hospital in Kenya41 that
50% of convulsions in malaria endemic settings can
be attributed to malaria. However, we cannot exclude
the possibility that estimates of incidence of convul-
sions based on reported data are biased. Our estimates
were about 10 times higher than those reported in
Kilifi (from 4300 to 2300 cases for every 100 000 chil-
dren per year between 2005 and 2008 compared
with 235 cases per 100 000 per year in 2006 in
Kenya). On one hand, it is recognized that hospital
estimates of incidence are lower than what would be
expected at community level in most of sub-Saharan
Africa where many cases are managed at home.42
The authors themselves caution that many children
with convulsions may have died without reaching
the hospital, and that a few may have been treated
successfully in peripheral health facilities. On the
other hand, it is likely that our estimates are too
high because of the same recall bias that was seen
for simple fever estimates: a rare and dramatic
event such as a convulsion in a small child might
have led to recall beyond the 2 weeks that we were
asking for.
Our data confirm that ‘caution is required when
using health facility-based data to evaluate the
health impact of malaria control efforts in Africa’.16
The main concern with health facility records is obvi-
ously their quality. Our experience shows that in the
absence of constant supervision records were often
not filled in properly. Acceptable reporting was only
achieved after 1 year of repeated visits and we had to
discard the data from the first year of data collection.
Furthermore, health facility staff mostly rely on
presumptive diagnosis of malaria in malaria endemic
countries.40 The data we presented here show that
the proportion of fever cases diagnosed did not
change throughout the year. Both during the
months of high transmission and during the months
of low transmission, two-thirds of fever cases were
systematically diagnosed as malaria. Rapid diagnostic
tests (RDT) for malaria were introduced in 3 out of
the 14 health facilities in the area in late 2007.
Although a decrease in malaria diagnoses was
observed in those facilities (Robert Tillya, manuscript
in preparation), this effect was diluted in our study
when the data were aggregated over all the facilities.
Beyond data quality issues, relying exclusively on
health facility data can lead to biases. First, such
data do not take population growth into account.
Our results clearly show that population growth can
affect results, since despite decreases in health facility
fever and malaria rates there was no impact on the
absolute number of cases seen in health facilities
which ultimately represents the burden of malaria at
health facility level. Second, health facility users are
not necessarily representative of the population at
large when the proportion of cases brought to a
health facility is low, which is often the case in
resource-limited countries.42 In our study, the decline
in community fevers was matched by a decline in
health facility fevers in children under the age of 5,
the majority of whom attended a health facility
(72%), but not in the overall population for whom
health facility attendance was much lower (estimated
between 45% and 57%).
Conclusions
The community burden of malaria morbidity declined
between 2005 and 2008 in the Kilombero and Ulanga
DSS, most likely as a result of malaria control efforts.
Meanwhile, the health facility burden remained un-
changed due to population growth. The good internal
and external consistency of our data strengthens our
conclusions and shows that history of fever in the
previous 2 weeks can be used as a community-based
morbidity-monitoring tool.
Funding
ACCESS programme, Novartis Foundation for
Sustainable Development.
414 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Acknowledgements
We thank the communities and the health facility
staff of the Kilombero and Ulanga districts for their
time and their patient collaboration with staff from
the Ifakara Health Institute. Many thanks to DSS
manager Mathew Alexander, supervisors Jensen
Charles and Chrisostom Mahutanga, as well as the
DSS field interviewers for a fruitful collaboration
with the ACCESS Programme. We acknowledge the
work of Amani Mono who supervised the entry of
the fever and convulsion data. This work would not
have been possible without the continued support of
all the other members of the ACCESS team, including
the project manager Dr Flora Kessy as well as
Christopher Mshana, Iddy Mayumana, Ahmed
Makemba and Dr Dominic Mboya. Special thanks to
Goodluck John who supervised the collection of the
health facility data throughout the entire study
period and to Hilda Mwakabusi who entered all the
health facility data. The ACCESS Programme is
funded by the Novartis Foundation for Sustainable
Development.
The various inputs provided by Prof. Tom Smith, Prof.
Blaise Genton, Prof. Joel Schwartz, Prof Don de
Savigny and Bendix Carstensen (through the
MedStats mailing list) were crucial in shaping the
data analysis of this paper. The INDEPTH network
supported SA to present the data at the 8th Annual
General Meeting, which allowed many fruitful ex-
changes with other participants that helped for this
article. Many thanks to Keith Purvis and Sri
Poedjastoeti from Macro International for disaggre-
gating the mortality data from the 2007/2008
Tanzania Malaria and HIV/AIDS Indicator Survey.
Conflict of interest: None declared.
KEY MESSAGES
 Between 2005 and 2008, the incidence of reported fever in children under the age of 5 years declined
by 34%, from 4.9 to 3.2 average cases per child per year in the Kilombero and Ulanga DSS areas in
Tanzania.
 This decrease is associated with improved treatment seeking as well as high coverage with ITNs.
 The good internal and external consistency of the data collected within the frame of this study shows
that history of fever in the previous 2 weeks in children under the age of 5 years can be used as a
morbidity-monitoring tool.
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